| (210) | Number of the EPO application | 20708757 |
| (220) | Filing date of the EPO application | 2020.01.24 |
| (80) | EPO patent specification publication (B) | EPB nr. 10/2024, 2024.03.06 |
| (110) | EPO patent number | 3914272 |
| (21) | Number of the application | e 2021 1144 |
| (71) | Name(s) of applicant(s), code of the country | JANSSEN PHARMACEUTICA NV, BE;
Montefiore Medical Center, US; |
| (72) | Name(s) of inventor(s), code of the country | EICHENBAUM Gary, BE;
GUHA Chandan, US; |
| (73) | Name(s) of owner(s), code of the country | JANSSEN PHARMACEUTICA NV, BE;
Montefiore Medical Center, US; |
| (54) | Title of the invention | THROMBOPOIETIN MIMETICS FOR MITIGATING LIVER INJURY AND PROMOTING LIVER HYPERTROPHY, REGENERATION AND CELL ENGRAFTMENT IN CONJUNCTION WITH RADIATION AND/OR RADIOMIMETIC TREATMENTS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 38/19 (2006.01.01); A61K 35/407 (2015.01.01); A61K 38/17 (2006.01.01); A61K 35/44 (2015.01.01); A61K 38/18 (2006.01.01); A61K 38/48 (2006.01.01); A61P 1/16 (2006.01.01) |
| (19) | Country | BE |
| (41) | Date of publication of the application | 2021.12.31 |
| (30) | Priority | 201962796806 P, 2019.01.25, US |
| (86) | International application | PCT/US2020/014934, 2020.01.24 |
| (87) | International publication | WO 2020/154585, 2020.07.30 |